A carregar...
The combination of checkpoint immunotherapy and targeted therapy in cancer
The therapeutic possibilities for patients with metastatic melanoma have changed due to the development of targeted therapies that inhibit oncogenic signaling pathways as well as immune modulating therapies that unleash the patient antitumor immunity. These therapeutic changes have impressively incr...
Na minha lista:
| Publicado no: | Ann Transl Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5653508/ https://ncbi.nlm.nih.gov/pubmed/29114546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.06.47 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|